ADUS vs. LHCG, CHE, OPCH, AMED, BTSG, AHCO, AVAH, EHAB, EHC, and BIO
Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include LHC Group (LHCG), Chemed (CHE), Option Care Health (OPCH), Amedisys (AMED), BrightSpring Health Services (BTSG), AdaptHealth (AHCO), Aveanna Healthcare (AVAH), Enhabit (EHAB), Encompass Health (EHC), and Bio-Rad Laboratories (BIO). These companies are all part of the "medical" sector.
LHC Group (NASDAQ:LHCG) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, community ranking, dividends, profitability, valuation, media sentiment and analyst recommendations.
Addus HomeCare has a net margin of 6.04% compared to Addus HomeCare's net margin of 2.73%. LHC Group's return on equity of 10.03% beat Addus HomeCare's return on equity.
LHC Group has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500.
83.5% of LHC Group shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 4.8% of LHC Group shares are owned by insiders. Comparatively, 4.6% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
LHC Group received 75 more outperform votes than Addus HomeCare when rated by MarketBeat users. However, 67.77% of users gave Addus HomeCare an outperform vote while only 58.50% of users gave LHC Group an outperform vote.
LHC Group has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than LHC Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Addus HomeCare had 8 more articles in the media than LHC Group. MarketBeat recorded 8 mentions for Addus HomeCare and 0 mentions for LHC Group. LHC Group's average media sentiment score of 0.81 beat Addus HomeCare's score of 0.22 indicating that Addus HomeCare is being referred to more favorably in the news media.
Addus HomeCare has a consensus target price of $116.25, indicating a potential downside of 5.89%. Given LHC Group's higher probable upside, analysts plainly believe Addus HomeCare is more favorable than LHC Group.
Summary
Addus HomeCare beats LHC Group on 11 of the 17 factors compared between the two stocks.
Get Addus HomeCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Addus HomeCare Competitors List
Related Companies and Tools
